Latest Breaking News On - Innovative vaccine - Page 4 : comparemela.com

/PRNewswire/ The Philippines has approved Recombinant Two-Component COVID-19 Vaccine (ReCOV) developed by Jiangsu Recbio Technology Co., Ltd. ("Recbio") for.

New zealandLiu yongFengcai zhuJiangsu medical products administrationTaizhou medical new industrial development zoneJiangsu recbio technology co ltdHuman healthInternational phaseJiangsu provincial centerRecombinant two componentGeneral managerPharmaceutical production licenseGood manufacturing practicesDisease controlTaizhou medical newHigh tech industrial development zone